Delivery Order SPE2DB25D3012-SPE2DB25FWYPD
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566416810 - Methylergonovine 0.2 mg/ml vials, with a ceiling value of $2,881.54 and a period of performance through November 14, 2024. The contract is a firm-fixed-price delivery order and was not designated as a set-aside. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,661.21 firm fixed-price delivery order is for the supply of methylergonovine 0.2 mg/ml, a medication used to treat postpartum hemorrhage. The contract has a completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $4,786.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of 4565427058 - Methylergonovine 0.2 mg/ml, a pharmaceutical product, to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,347.93 firm fixed-price delivery order is for the supply of 4565150115 - Methylergonovine 0.2 mg Tablet 12s, with a completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,196.64 firm fixed-price delivery order is for the supply of 4565223784 ! METHYLERGONOVINE 0.2 MG/ML VLML, a pharmaceutical product. The contract has a completion date of July 24, 2024 and was awarded on July 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $2,393.28 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract utilizes firm fixed pricing with an ultimate completion date of September 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Methylergonovine 0.2 mg/mL injection vials, with a firm fixed price of $1,355.56 and an ultimate completion date of September 16, 2025. This non-competitive delivery order represents a single-transaction pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of methylergonovine 0.2 mg/ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,723.80 and an ultimate completion date of August 18, 2022. It is not set aside for any special program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylergonovine 0.2 mg tablets, a medication used to treat postpartum hemorrhage. The contract has a firm fixed price of $1,208.02 and a period of performance through April 11, 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,196.64 fixed-price contract is for the supply of 4565545266 - Methylergonovine 0.2 mg/ml vials. The contract has an ultimate completion date of August 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds significant indefinite delivery contracts (IDCs) with the DLA and Department of Justice Federal Bureau of...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYPDDelivery Order
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a Defense agency. The contract is for the delivery of Methylergonovine 0.2 mg/ml injectable medication, with a fixed-price ceiling value of $4,089.08 and a completion date of July 14, 2025. The contract is not set aside for any particular business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/11/25 |